Prevalence of CCR5 and CCR2 HIV-coreceptor gene polymorphisms in Belgium

被引:26
|
作者
Struyf, F
Thoelen, I
Charlier, N
Keyaerts, E
Van der Donck, I
Wuu, J
Van Ranst, M
机构
[1] Rega Inst Med Res, Dept Microbiol & Immunol, Virol Lab, B-3000 Louvain, Belgium
[2] Univ Massachusetts, Ctr Canc, Div Biostat & Epidemiol, Worcester, MA 01605 USA
关键词
CCR5; CCR2; chemokine receptors; polymorphism; HIV; acquired immunodeficiency syndrome; Belgium;
D O I
10.1159/000022932
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Polymorphisms of the chemokine receptor genes CCR5 and CCR2 are associated with resistance to HIV-1 infection or delayed progression to AIDS. Few data are available on their combined prevalence in healthy subjects; we therefore examined the occurrence of CCR5-Delta 32 and CCR2-641 polymorphisms in a sample of 310 healthy Belgians. Allele frequencies were 0.119 and 0.074 for CCR5-Delta 32 and CCR2-641, respectively, Genotype distributions for both polymorphisms were found to be in accordance with Hardy-Weinberg equilibrium, but a significant (p = 0.002) linkage disequilibrium between CCR5-Delta 32 and CCR2-641 was observed. The high prevalence of CCR5-Delta 32 and CCR2-641 in Belgians may need to be taken into account in the design of studies of antiretroviral treatments, Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:304 / 307
页数:4
相关论文
共 50 条
  • [31] Extensive gene conversion between CCR2 and CCR5 in domestic cat (Felis catus)
    Esteves, P. J.
    Abrantes, J.
    van der Loo, W.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2007, 34 (05) : 321 - 324
  • [32] Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice
    Mack, M
    Cihak, J
    Simonis, C
    Luckow, B
    Proudfoot, AEI
    Plachy, J
    Brühl, H
    Frink, M
    Anders, HJ
    Vielhauer, V
    Pfirstinger, J
    Stangassinger, M
    Schlöndorff, D
    JOURNAL OF IMMUNOLOGY, 2001, 166 (07): : 4697 - 4704
  • [33] CENICRIVIROC MESILATE Chemokine CCR2/CCR5 Receptor Antagonist Anti-HIV Agent
    Reviriego, C.
    DRUGS OF THE FUTURE, 2011, 36 (07) : 511 - 517
  • [34] HIV-1 co-receptor CCR5 and CCR2 mutations among Greeks
    Papa, A
    Papadimitriou, E
    Adwan, G
    Clewley, JP
    Malissiovas, N
    Ntoutsos, I
    Alexiou, S
    Antoniadis, A
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2000, 28 (01): : 87 - 89
  • [35] CCR2, CCR5, and CXCL12 variation and HIV/AIDS in Papua New Guinea
    Mehlotra, Rajeev K.
    Hall, Noemi B.
    Bruse, Shannon E.
    John, Bangan
    Zikursh, Melinda J. Blood
    Stein, Catherine M.
    Siba, Peter M.
    Zimmerman, Peter A.
    INFECTION GENETICS AND EVOLUTION, 2015, 36 : 165 - 173
  • [36] Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population
    Apostolakis, S
    Baritaki, S
    Krambovitis, E
    Spandidos, DA
    JOURNAL OF CLINICAL VIROLOGY, 2005, 34 (04) : 310 - 314
  • [37] Analysis of the chemokine receptors CCR2/CCR5 polymorphisms in Spanish patients with systemic lupus erythematosus (SLE).
    Aguilar, F
    Núñez-Roldán, A
    Torres, B
    Wichmann, I
    Sánchez-Román, J
    González-Escribano, MF
    GENES AND IMMUNITY, 2003, 4 : S16 - S16
  • [38] Possible contribution of chemokine receptor CCR2 and CCR5 polymorphisms in the pathogenesis of chronic spontaneous autoreactive urticaria
    Brzoza, Z.
    Grzeszczak, W.
    Rogala, B.
    Trautsolt, W.
    Moczulski, D.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2014, 42 (04) : 302 - 306
  • [39] Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders
    Laura Fantuzzi
    Maria Tagliamonte
    Maria Cristina Gauzzi
    Lucia Lopalco
    Cellular and Molecular Life Sciences, 2019, 76 : 4869 - 4886
  • [40] A dual CCR2/CCR5 chemokine antagonist, BMS-813160?
    Norman, Peter
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2011, 21 (12) : 1919 - 1924